Michael Whitlow
Clinical & Laboratory Dermatological Immunology · New York, NYNPI 1669431979
Payments from drug & device makers
Across 232 payments — averaging $21.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$776
- E.r. Squibb & Sons, L.L.C.$446
- Novartis$399
- Pfizer$344
- UCB, Inc.$342
- plus $1K from 13 others
What the payments were for
- Food & beverage$4,76496%
- Education$1994%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 62 | $1,290 |
| Johnson & Johnson | 31 | $776 |
| E.r. Squibb & Sons, L.L.C. | 30 | $446 |
| Novartis | 19 | $399 |
| Pfizer | 16 | $344 |
| UCB, Inc. | 13 | $342 |
| Galderma Laboratories, L.p. | 12 | $259 |
| Lilly USA, LLC | 11 | $214 |
| Amgen | 8 | $186 |
| Incyte Corporation | 7 | $176 |
| LEO Pharma Inc. | 9 | $172 |
| Sanofi | 5 | $160 |
| Sun Pharmaceutical Industries Inc. | 2 | $50 |
| Arcutis Biotherapeutics, Inc. | 2 | $44 |
| Organon | 1 | $30 |
| Almirall LLC | 1 | $25 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Journey Medical Corporation | 1 | $14 |
How this compares
Too few clinical & laboratory dermatological immunology providers in New Yorkto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 15 | $182,811 |
| Clobetasol Propionate | 119 | $5,857 |
| Mycophenolate Mofetil | 33 | $2,656 |
| Triamcinolone Acetonide | 120 | $2,601 |
| Cyclosporine ModifiedCyclosporine, Modified | 18 | $1,378 |
| Metronidazole | 18 | $1,278 |
| Famciclovir | 11 | $1,056 |
| Clindamycin Phosphate | 43 | $1,010 |
| Imiquimod | 27 | $761 |
| Minocycline Hcl | 13 | $619 |
| Econazole Nitrate | 15 | $601 |
| Hydrocortisone | 71 | $435 |
| Mupirocin | 37 | $323 |
| Prednisone | 20 | $293 |
| Minoxidil | 20 | $256 |
Paid to pharmacies, not to this prescriber.
Other clinical & laboratory dermatological immunology in New York
- Donald BelsitoNew York$90K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.